GlassScriptPhysician profile
Rolf N Barth
NPI 1861435182
$1,941.41
in general payments reported to CMS, 2019-2025
10 companies · $267 in 2025
The $267 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $360 · 2021: $618 · 2023: $201 · 2024: $361 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $880.98 | 2021-2025 | |
| Abbvie INC. | $240.95 | 2019-2020 | |
| Veloxis Pharmaceuticals, INC. | $240.28 | 2020 | |
| Paragonix Technologies, INC. | $201.34 | 2024 | Baroguard, Liverguard, Lungguard |
| Organox LTD | $166.80 | 2023 | Metra |
| United Therapeutics Corporation | $124.93 | 2021 | |
| Medtronic, INC. | $39.14 | 2024 | Signia |
| Organ Recovery Systems, INC. | $34.09 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.90 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolf Barth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.